Skip to main content
Top
Published in: Gastric Cancer 3/2006

01-08-2006 | Review article

Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach

Authors: Ryoji Kushima, Michael Vieth, Franz Borchard, Manfred Stolte, Ken-ichi Mukaisho, Takanori Hattori

Published in: Gastric Cancer | Issue 3/2006

Login to get access
Metadata
Title
Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach
Authors
Ryoji Kushima
Michael Vieth
Franz Borchard
Manfred Stolte
Ken-ichi Mukaisho
Takanori Hattori
Publication date
01-08-2006
Publisher
Springer-Verlag
Published in
Gastric Cancer / Issue 3/2006
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-006-0381-8

Other articles of this Issue 3/2006

Gastric Cancer 3/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine